Bismatrol

Quick links to important sections

Bismatrol

Method of action: Antacid, Bismuth Containing

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Bismatrol

Property Description
Active ingredient Bismuth Subsalicylate
Form Oral Liquid Suspension, Chewable Tablet, Caplet
Pharmacological class Antidiarrheal Agent, Antisecretory Agent
Common use Relief of digestive discomfort
Origin Derived (Semi-synthetic complex compound)

Bismatrol: A High-Level Definition and Classification

Bismatrol is an established over-the-counter (OTC) medication classified primarily as a gastrointestinal agent, widely recognized for managing common digestive discomfort.

The single active ingredient is Bismuth Subsalicylate, which places it within two critical pharmacological classes: an Antidiarrheal Agent and an Antisecretory Agent. The compound's function is clinically recognized for managing symptoms associated with transient stomach irritation. The medication is prepared for oral (Peroral) administration, most commonly as an Oral Liquid Suspension—a distinguishing feature compared to solid-only preparations—and also in alternative formats like chewable tablets and caplets.

Composition and Dual Nature of Bismuth Subsalicylate

The active component, Bismuth Subsalicylate, is a single-active-ingredient product synthesized as a complex compound combining an inorganic bismuth salt and a salicylate derivative.

This compound is semi-synthetic in origin, utilizing the unique properties of both components. The presence of the subsalicylate ion sets it apart chemically from basic adsorbents and contributes to its functional complexity. Bismuth Subsalicylate is an ingredient that acts as a gastrointestinal protectant. This chemical design confers the tripartite action necessary for its broad localized performance.

General Purpose: How Bismatrol Helps the Digestive System

The overall general purpose of Bismatrol is to help settle and restore comfort to the digestive system during periods of common stomach and intestinal irritation, such as when experiencing a non-severe temporary digestive upset.

This benefit is achieved through the compound's specialized mechanism principles. It acts as a protectant by coating irritated tissue and functions as an antisecretory agent to reduce the movement of excess fluids and electrolytes into the bowel. This dual function provides comprehensive support for the gut lining and helps manage internal fluid balance, a critical physiological step in relieving discomfort.

Regulatory References

  1. MedlinePlus

What side effects are possible with Bismatrol?

Possible Side Effects and Safety Information

The official safety profile for Bismatrol (Bismuth Subsalicylate) is defined by its components and is categorized into expected, non-serious effects and rare, serious systemic risks, as documented by regulatory authorities.

Adverse Reaction Classification

Side effects are primarily classified within the Gastrointestinal Disorders and Ear and Labyrinth Disorders system-organ classes.

Category of Effect Manifestation Regulatory Note
Expected & Common Darkening of the stool, Darkening of the tongue Often noted as temporary and harmless when using the product.
Ear & Labyrinth Tinnitus (ringing in the ears), Hearing loss Associated with the potential for salicylate toxicity.
Gastrointestinal Constipation An officially listed adverse reaction.

Serious Adverse Reactions and Safety Restrictions

Official labeling documents a specific, serious safety restriction: Bismatrol must not be used in children or teenagers recovering from viral illnesses (e.g., chickenpox or flu), due to the associated risk of Reye's Syndrome, a rare but severe condition related to salicylate use.

The product contains salicylate and is officially prohibited for use in individuals with known salicylate allergies (including aspirin), those taking other salicylate products, or patients with an ulcer or bleeding problem due to potential increased risk.

Safety notes also constrain use with specific medications such as anticoagulants, and in conditions like gout or diabetes. The darkening of the stool and tongue is generally a temporary, physical change associated with the bismuth component, not a sign of internal bleeding.

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory information describes overdose manifestations for Bismatrol (Bismuth Subsalicylate) as primarily related to salicylate toxicity (salicylism). The documented signs and symptoms may include tinnitus (ringing in the ears), temporary hearing loss, confusion, lethargy, severe drowsiness, vomiting, and abnormal hyperventilation. Physiologically, overdose is associated with metabolic changes such as metabolic acidosis and hypoglycaemia.

Documented Severe Outcomes

Severe manifestations documented in official labeling that necessitate urgent attention include seizures (convulsions), unconsciousness, non-cardiac pulmonary oedema, and renal failure. Chronic, excessive exposure is officially linked to the risk of bismuth neurotoxicity.

Required Emergency Action

Government guidance explicitly mandates that individuals must seek immediate medical attention upon the suspicion of an overdose. You must get emergency help at once or contact a Poison Control Center right away. Emergency services must be called if the individual has collapsed, seized, or is experiencing difficulty breathing.

Overdose Management Notes

The regulatory profile states that no specific antidote is known for this toxicity. Management involves symptomatic and supportive treatment. This may include gastrointestinal decontamination with activated charcoal and advanced procedures like haemodialysis in severe cases. Individuals with renal impairment or the elderly may be at a greater risk for increased toxicity.

Therapeutic Uses of Bismatrol

Bismatrol: Main Uses and Benefits

Bismatrol, the common name for bismuth subsalicylate, is a widely available medication indicated for the temporary management of various symptoms related to gastrointestinal discomfort. Its primary therapeutic domains include relieving occasional diarrhea and addressing symptoms of an upset stomach.

This medication may contribute to the reduction of symptoms such as heartburn, indigestion, and feelings of fullness or gas. It is also used to help alleviate nausea associated with temporary gastrointestinal distress. For individuals experiencing diarrhea, including traveler's diarrhea, Bismatrol may help in controlling symptoms and lessening the frequency of loose stools.

Bismuth subsalicylate is a component in certain combination regimens utilized for the management of Helicobacter pylori infection, which is often associated with duodenal ulcers.


Quick Facts: Therapeutic Uses

  • Relief of Occasional Diarrhea: May help control the symptoms of loose or watery stools, including traveler’s diarrhea.
  • Management of Upset Stomach: May help alleviate temporary discomforts such as heartburn, indigestion, and nausea.
  • Symptom Reduction: May contribute to reducing gas and feelings of abdominal fullness.
  • Combination Therapy: Used as a component in certain regimens for the management of H. pylori.

Regulatory References

  1. NIH MedlinePlus guidance

Eligibility and Restrictions for Use

Eligibility for Bismatrol (Bismuth Subsalicylate) Use

Official regulatory guidelines strictly define the populations eligible to use Bismatrol, primarily based on age and the risks associated with its salicylate component. Use is generally approved for adults and adolescents 12 years of age and older.


Mandatory Restrictions and Contraindications

Bismatrol is contraindicated and must not be used by specific groups as determined by regulatory authorities:

  • Salicylate Sensitivity: Individuals with a known allergy or hypersensitivity to salicylates (including aspirin).
  • Gastrointestinal Conditions: Patients with existing stomach ulcers or active gastrointestinal bleeding.
  • Viral Illness in Youth: Children and teenagers with or recovering from chickenpox or influenza (flu-like symptoms), due to the associated risk of Reye's syndrome.
  • Pregnancy (Late Term): Women in the third trimester of pregnancy.

Conditional Use and Caution

Use is not recommended for children under 12 for general relief and is advised with caution in women who are breastfeeding. Special caution is also required for patients with severe renal (kidney) impairment, liver disease, and conditions like gout, due to the potential for salicylate accumulation or interference, as explicitly stated in product labeling.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documentation structures the interaction profile of Bismatrol (Bismuth Subsalicylate) based on two primary chemical components: the salicylate derivative and the bismuth salt.

Interactions from the Salicylate Component

The salicylate component can lead to pharmacodynamic potentiation of certain medicines. Co-administration with Anticoagulants (such as Warfarin) is documented as increasing the risk of bleeding by potentiating the anticoagulant effect. Similarly, the salicylate component may increase the activity of Oral Hypoglycemic Agents. Conversely, Bismatrol can reduce the therapeutic efficacy of Uricosuric Agents (gout medications) and is associated with an increased risk of toxicity when combined with Methotrexate. Use with other salicylates or NSAIDs is officially restricted due to the additive risk of adverse effects.

Interactions from the Bismuth Component

The bismuth salt component causes a physicochemical chelation interaction. This mechanism demonstrably decreases the absorption of Tetracycline Antibiotics (e.g., Doxycycline, Minocycline). To minimize this reduction in exposure, regulatory labels require that the administration of these antibiotics and Bismatrol be separated by a mandatory timing rule.

Substance and Population Restrictions

Interactions with substances like Alcohol and the herbal product Gingko Biloba are officially noted as potentially increasing the risk of bleeding. Furthermore, Bismatrol is officially contraindicated for use in children and teenagers recovering from viral illnesses, such as flu or chickenpox, due to the documented link between salicylates and the risk of Reye's syndrome.

Mechanism of Action

How Bismatrol Works

The mechanism of Bismatrol relies on a tripartite action in the gastrointestinal tract, derived from the local effects of its bismuth and salicylate components acting on distinct biological targets and pathways to modulate dysregulated physiological responses.


u1f500 Modulation of Intestinal Secretion via Enzyme Inhibition

The salicylate moiety acts as a local inhibitor of Cyclooxygenase (COX) enzymes within the intestinal mucosa. By blocking the synthesis of pro-inflammatory prostaglandins, the drug dampens a key signaling cascade that drives excessive fluid and electrolyte secretion into the gut lumen, thereby contributing to the reversal of pathological hypersecretion and the modulation of hypermotility.


u1f6a7 Physical Cytoprotection and Toxin Neutralization

The bismuth moiety performs two direct physicochemical actions. It forms an insoluble protective barrier over irritated mucosal tissue, providing epithelial cytoprotection. Simultaneously, it functions as an adsorbent, binding to and neutralizing specific bacterial enterotoxins and interfering with the metabolism of certain local pathogens, which limits toxin-mediated cellular damage and subsequent secretory responses.

Dosage and Administration Information

Official Administration Guidelines

Bismatrol (bismuth subsalicylate) is administered exclusively by the oral route for standard use. The medicine is available as an oral suspension (liquid), chewable tablets, and swallowable tablets (caplets). Proper administration is essential and must follow the specific instructions on the product label.


Instruction Component General Rule
Preparation Liquid forms must be shaken well before each use, and the dose should be measured using the provided dosing cup.
Administration Chewable tablets must be chewed or dissolved in the mouth. Swallowable tablets must be taken whole with water.
Standard Dosing The typical adult dose is 524 mg (or 30 mL of regular-strength suspension) taken every half-hour to one hour as needed.
Frequency Limit Do not exceed 8 regular-strength doses in any 24-hour period. Do not use for standard purposes for more than 2 days.
Pediatric Rules Children and teenagers who are recovering from flu-like symptoms or chickenpox should not use this product due to the risk of Reye's syndrome.

If a dose is missed when following a prescribed schedule (e.g., for H. pylori therapy), do not take a double dose; continue the regular schedule until the medication is gone. Adherence to these strict dose limits and procedural steps is the required protocol.

Recent Clinical Evidence

Bismatrol: Recent Clinical Evidence


Evidence for Managing Acute Diarrhea and Upset Stomach

The primary evidence base for Bismatrol, encompassing Randomized Controlled Trials (RCTs) and Systematic Reviews, has explored its application in the context of acute diarrhea. Studies monitored changes in stool frequency and duration in adults and travelers over short time intervals. Separately, regulatory evidence reviews have examined Bismatrol’s use for temporary upper gastrointestinal (GI) discomfort, including symptoms like nausea, fullness, and indigestion.

The research for these indications is specific to temporary, non-severe conditions, and follow-up durations are generally limited to the acute phase.


Evidence as a Component in Specialized Regimens

Research has evaluated Bismatrol as one part of a multi-drug regimen for the management of Helicobacter pylori infection, which is often associated with duodenal ulcers. RCTs and Systematic Reviews monitored the measured rate of bacterial elimination (eradication) and patterns of ulcer recurrence after the study period.

This evidence is specific to the combined therapy, and comparative evidence for Bismatrol's use alone against the infection is lacking. The measured success of these regimens may be dependent on the maintenance of the full multi-drug schedule throughout the study period.


Research into Preventative Use and Key Limitations

Bismatrol was studied for its use as a preventative measure to reduce the incidence of Traveler's Diarrhea (TD). RCT findings were mixed across studies; some historical research reported a difference in measured rates, while other recent trials reported outcomes that were not clearly differentiated from the control group. Certainty remains low in this specific application.

Overall, data for certain groups remain insufficient, particularly for children under 12 years of age. Follow-up durations are limited across most applications, meaning long-term effects regarding the durability of response are not fully established. The research does not determine whether an individual will respond similarly to the observed group patterns.

Frequently Asked Questions (FAQ)

Common questions about Bismatrol (FAQ)

Q: How long does it typically take for Bismatrol to start working?

A: Clinical guides that review this medication indicate that the effects may begin to be noticeable within 30 to 60 minutes after taking the medicine. The onset of action is generally described as occurring within a short timeframe for the product's intended uses.

Q: Can Bismatrol be taken with food, or does it need to be on an empty stomach?

A: Official information regarding the administration of Bismatrol notes that the medicine can be taken with or without food. The choice of timing can be based on individual preference, as official information indicates food does not alter the product's intended function.

Q: Is Bismatrol available over the counter, or do I need a prescription?

A: Bismatrol is generally available as an Over-the-Counter (OTC) human drug product in its common forms and strengths. While some specialized, multi-drug treatment regimens that include Bismatrol may be prescribed, the medication itself is typically accessible without a prescription.

Q: Are there any major food or drink restrictions while using Bismatrol?

A: Official documents caution about co-administration with Alcohol due to a potential for an increased risk of bleeding. The product warnings should be reviewed for any concerns about consuming specific foods or beverages.

Q: Can I take Bismatrol if I am also taking an antibiotic?

A: It is important to be aware that the medicine may decrease the absorption of certain Tetracycline antibiotics (such as Doxycycline or Minocycline) through a chemical process called chelation. For this reason, official guidelines state that Bismatrol and Tetracycline antibiotics should be administered at separate times.

Q: Does taking Bismatrol help prevent traveler's diarrhea?

A: Official product labeling for Bismatrol includes the prevention of traveler's diarrhea as a specific labeled use. Research has evaluated its use in this application, and official product use is recognized in this context.

Q: Can I crush or chew Bismatrol tablets?

A: This depends on the specific form: chewable tablets must be chewed or dissolved in the mouth. However, swallowable tablets (caplets) are directed to be taken whole with water and should not be crushed.

Q: What should I do if I forget a dose of Bismatrol?

A: For individuals taking Bismatrol as part of a prescribed multi-drug regimen (such as for H. pylori), official guidelines state to not take a double dose if a dose is missed. The regular schedule should be continued as planned.

Q: How long do the effects of Bismatrol last after one dose?

A: A specific duration of action is not typically stated on product labels. However, official administration guidelines allow for repeat dosing every half-hour to one hour as needed, up to the maximum daily limit, which corresponds to the time interval permitted before another dose can be taken.

Q: Does Bismatrol affect the way other medicines are absorbed?

A: Yes, the bismuth component can cause a physicochemical chelation interaction. This mechanism can demonstrably decrease the absorption of certain medicines, particularly Tetracycline Antibiotics, which is why timing separation is advised in product labeling.

Q: Is it safe to take Bismatrol every day?

A: Regulatory labels for general use specify that the product should not be used for more than 2 days unless directed by a health professional. Adherence to this short-term use limit is consistent with the standard protocol for non-prescribed use.

Q: Are there any long-term effects of using Bismatrol?

A: Salicylism, which includes symptoms like ringing in the ears, has been reported in cases of prolonged and excessive ingestion over many weeks or months. Nervous system toxicity has also been reported in rare cases of prolonged, excessive bismuth ingestion.

Q: Can Bismatrol cause constipation?

A: Constipation is listed in the official safety profile as an officially recognized adverse reaction. This is one of the possible effects noted in regulatory documentation.

Q: Is Bismatrol safe for people with kidney problems?

A: Official documentation requires special caution for use in patients with severe renal (kidney) impairment. This is because the salicylate component is cleared by the kidneys, and impairment could lead to accumulation.

Q: Are there different strengths or forms of Bismatrol (e.g., liquid, chewable)?

A: Yes, the medication is available in several dosage forms, including oral suspensions and chewable or swallowable tablets. Official product information confirms these forms come in different strengths (e.g., regular and maximum/extra strength) tailored to various patient needs.

Q: Does Bismatrol help with gas or bloating?

A: Official product labeling includes the relief of symptoms such as gas and belching (burping) as indications for use. This means the medicine is intended to help with these specific types of digestive discomfort.

Q: Why do official documents sometimes mention Bismatrol being used for H. pylori?

A: Bismatrol is often included as one part of a multi-drug regimen for H. pylori infection. Research indicates the bismuth compound has a local action in the stomach that may impede proton entry into the bacteria, thereby increasing the effectiveness of the antibiotics used in the treatment.

Q: Is Bismatrol known by any other brand names?

A: Bismatrol is a common reference for the active ingredient, Bismuth Subsalicylate. This ingredient is available under numerous brand names, including the widely known product Pepto-Bismol.

Q: Does Bismatrol have to be stored in the refrigerator?

A: No. Official requirements specify storing the medicine at controlled room temperature and protecting the liquid suspension from freezing. Refrigeration is generally not required, and freezing should be avoided.

Q: Can Bismatrol cause any allergic reactions?

A: As with any medication, there is a risk of a severe allergic reaction. Regulatory guidance notes that signs like hives, swelling of the face, or difficulty breathing require immediate medical attention.

Q: Do studies suggest Bismatrol is effective for general indigestion?

A: Yes, official product labeling includes indigestion as an indication for use. Evidence reviews cite its effectiveness for a range of symptoms related to temporary upper GI discomfort, such as nausea and stomach fullness.

Q: Are there any known interactions between Bismatrol and herbal supplements?

A: Official interaction warnings specifically mention the herbal product Gingko Biloba as a potential risk factor for bleeding. Information on other herbal supplements is not consistently established in regulatory labeling.

Q: Can Bismatrol be taken during pregnancy?

A: Regulatory guidance advises that if a person is pregnant or breastfeeding, they should consult a healthcare professional before use. The product is contraindicated (prohibited) during the third trimester of pregnancy.

Q: Does Bismatrol have any sugar or artificial sweeteners?

A: Some product forms, such as certain chewable tablets, may list ingredients like aspartame (an artificial sweetener) and various fillers in their inactive ingredients list. The specific product label provides the most accurate information to determine content.

Q: Is it possible to take too much Bismatrol?

A: Yes, official product labeling includes a warning for overdose and directs users to immediately contact a poison control center for medical help in such an event. It is important not to exceed the recommended frequency limits.

Q: Can Bismatrol be used to help with heartburn?

A: Official product labeling includes the relief of heartburn as one of the specific uses for the medicine. This is part of its overall indication for treating common digestive discomfort.

Q: Why is Bismatrol sometimes referred to as a heavy metal compound?

A: The active ingredient is Bismuth Subsalicylate. Bismuth, the core element in this compound, is chemically classified by scientists as a naturally occurring heavy metal element.

How should Bismatrol be stored and disposed of?

How to Store and Dispose of Bismatrol

Storage of Bismatrol (bismuth subsalicylate) must adhere to the conditions specified in official regulatory labeling to ensure product stability.


Storage Requirements

Condition Requirement
Temperature Store at controlled room temperature, between 15°C and 30°C (59°F and 86°F).
Avoid Extremes Protect the medicine from excessive heat (above 40°C) and protect the liquid suspension from freezing.
Protection The tablet form must be protected from moisture to maintain integrity.
Child Safety The product must be kept out of the reach of children.

Disposal Instructions

Unused or expired Bismatrol should be disposed of according to official guidance. The preferred method is using an authorized drug take-back program. If a program is unavailable, the medicine can be disposed of in household trash by mixing it with an undesirable substance, sealing it in a container, and discarding it.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Bismatrol found in:

A-Z Index: